← Back to Clinical Trials
Recruiting NCT05812248

NCT05812248 Prediction of Vascular Events After Major Non-Cardiac Surgery : an Observational Prospective Cohort Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05812248
Status Recruiting
Phase —
Sponsor Nanfang Hospital, Southern Medical University
Condition Noncardiac Surgery
Study Type OBSERVATIONAL
Enrollment 20,000 participants
Start Date 2022-07-01
Primary Completion 2027-11

Eligibility & Interventions

Sex All sexes
Min Age 45 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Perioperative cardiac biomarker measurement

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 20,000 participants in total. It began in 2022-07-01 with a primary completion date of 2027-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This observational study includes patients at medium-to-high cardiovascular risks undergoing major noncardiac surgery, measures their baseline demographic and clinical characteristics, preoperative cardiac biomarkers and intraoperative surgery/anesthesia related data, and screens them for the occurrence of myocardial injury and major adverse cardiac events after surgery. The primary aim is to develop and validate a pre- and an immediate postoperative prediction model for occurrence of major adverse cardiac events.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 45 years; * Undergoing major noncardiac surgery (expected procedure duration ≥2 h, expected length of postoperative stay ≥2 d); * History of at least one cardiovascular disease (i.e., coronary artery disease, stroke, congestive heart failure, or peripheral arterial disease) or with at least two cardiovascular risk factors (i.e., hypertension, diabetes, chronic kidney disease, smoking in the past ≥2 years, ≥65 years of age, hypercholesterolemia, history of TIA, high-risk surgery (intrathoracic, intraperitoneal, or major vascular)). Exclusion Criteria: * History of acute cardiovascular events within 30 days prior to surgery; * American Society of Anesthesiologists (ASA) physical status of 5 or greater; * Previously enrolled in this study; * Unable to understand or to sign informed consent.

Contact & Investigator

Central Contact

Bingcheng Zhao, MD

✉ zhaobch@mail2.sysu.edu.cn

📞 86-13763313653

Frequently Asked Questions

Who can join the NCT05812248 clinical trial?

This trial is open to participants of all sexes, aged 45 Years or older, studying Noncardiac Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05812248 currently recruiting?

Yes, NCT05812248 is actively recruiting participants. Contact the research team at zhaobch@mail2.sysu.edu.cn for enrollment information.

Where is the NCT05812248 trial being conducted?

This trial is being conducted at Guangzhou, China.

Who is sponsoring the NCT05812248 clinical trial?

NCT05812248 is sponsored by Nanfang Hospital, Southern Medical University. The trial plans to enroll 20,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology